UK government targets manufacturing as it eyes £41bn life science sector growth
With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.
Business & Regulation
Leading medical groups sue RFK Jr and HHS over ‘hostile’ vaccine policies
Big pharma braces for revenue headwinds as patent expiries loom
Theratechnologies shares surge 25% amid $254m Future Pak takeover
How will RFK Jr’s American dream for vaccines play out?
Bavarian Nordic nets $160m from priority review voucher sale
FDA creates new priority review voucher scheme to boost US interests
Trump’s push to onshore pharma manufacturing clouded by ‘lack of clarity’
